As of 2025-11-15, the EV/EBITDA ratio of Orthofix Medical Inc (OFIX) is -60.30. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OFIX's latest enterprise value is 702.43 mil USD. OFIX's TTM EBITDA according to its financial statements is -11.65 mil USD. Dividing these 2 quantities gives us the above OFIX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.9x - 15.8x | 12.8x |
| Forward P/E multiples | 9.9x - 20.7x | 11.8x |
| Fair Price | (6.00) - (7.44) | (6.41) |
| Upside | -140.0% - -149.6% | -142.7% |
| Date | EV/EBITDA |
| 2025-11-14 | -59.49 |
| 2025-11-13 | -60.30 |
| 2025-11-12 | -61.29 |
| 2025-11-11 | -61.56 |
| 2025-11-10 | -60.37 |
| 2025-11-07 | -60.14 |
| 2025-11-06 | -59.19 |
| 2025-11-05 | -60.17 |
| 2025-11-04 | -59.83 |
| 2025-11-03 | -63.86 |
| 2025-10-31 | -61.76 |
| 2025-10-30 | -61.86 |
| 2025-10-29 | -61.36 |
| 2025-10-28 | -63.73 |
| 2025-10-27 | -63.93 |
| 2025-10-24 | -63.56 |
| 2025-10-23 | -63.39 |
| 2025-10-22 | -64.44 |
| 2025-10-21 | -62.71 |
| 2025-10-20 | -62.37 |
| 2025-10-17 | -60.47 |
| 2025-10-16 | -61.12 |
| 2025-10-15 | -60.41 |
| 2025-10-14 | -59.56 |
| 2025-10-13 | -58.58 |
| 2025-10-10 | -57.56 |
| 2025-10-09 | -56.95 |
| 2025-10-08 | -58.14 |
| 2025-10-07 | -57.56 |
| 2025-10-06 | -57.46 |
| 2025-10-03 | -58.95 |
| 2025-10-02 | -57.59 |
| 2025-10-01 | -58.03 |
| 2025-09-30 | -59.05 |
| 2025-09-29 | -58.10 |
| 2025-09-26 | -57.86 |
| 2025-09-25 | -58.17 |
| 2025-09-24 | -59.59 |
| 2025-09-23 | -59.42 |
| 2025-09-22 | -59.80 |
| 2025-09-19 | -59.29 |
| 2025-09-18 | -61.90 |
| 2025-09-17 | -60.07 |
| 2025-09-16 | -59.73 |
| 2025-09-15 | -59.42 |
| 2025-09-12 | -59.97 |
| 2025-09-11 | -60.27 |
| 2025-09-10 | -57.73 |
| 2025-09-09 | -58.95 |
| 2025-09-08 | -59.25 |